Serratus Posterior Superior Intercostal Plane Block Versus Intrathecal Morphine in VATs
Comparison of the Effects of Serratus Posterior Superior Intercostal Plane Block and Intrathecal Morphine on Postoperative Acute Pain in Patients Undergoing Video-assisted Thoracoscopic Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to compare the analgesic effects of the serratus posterior superior intercostal plane block and intrathecal morphine in patients undergoing video-assisted thoracoscopic surgery. This is a prospective, randomized, controlled, single-center clinical trial including adult patients undergoing elective thoracoscopic surgery. Participants will be randomly assigned to receive either a serratus posterior superior intercostal plane block or intrathecal morphine before general anesthesia. The primary outcome is cumulative opioid consumption during the first 24 postoperative hours, expressed as intravenous morphine milligram equivalents. Secondary outcomes include pain scores, time to first analgesic request, quality of recovery, and postoperative complications. The study aims to determine whether these two techniques differ in their effectiveness for postoperative pain management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
May 4, 2026
April 1, 2026
5 months
April 9, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative opioid consumption within 24 hours after surgery
Total opioid consumption during the first 24 postoperative hours is expressed as intravenous morphine milligram equivalents, including patient-controlled analgesia and rescue analgesia.
24 hours
Secondary Outcomes (14)
Cumulative opioid consumption within 12 hours after surgery
12 hours
Postoperative pain scores
0, 3, 6, 12, 18, and 24 hours postoperatively
Time to first patient-controlled analgesia demand
24 hours
Quality of recovery score
Preoperative baseline, 24 hours postoperatively, and at discharge
Postoperative nausea and vomiting
0, 3, 6, 12, 18, and 24 hours postoperatively
- +9 more secondary outcomes
Other Outcomes (2)
Heart Rate
Intraoperative period (up to 4 hours)
Mean Arterial Pressure
Intraoperative period (up to 4 hours)
Study Arms (2)
Intrathecal Morphine
EXPERIMENTALParticipants receive intrathecal morphine before induction of general anesthesia. Intrathecal morphine is administered at a dose of 5 micrograms per kilogram in 3 milliliters of saline via spinal injection. All patients subsequently undergo standardized general anesthesia and receive postoperative patient-controlled analgesia with intravenous morphine.
Serratus Posterior Superior Intercostal Plane Block
EXPERIMENTALParticipants receive an ultrasound-guided serratus posterior superior intercostal plane block before induction of general anesthesia. A total of 30 milliliters of 0.25 percent bupivacaine with epinephrine is administered into the interfascial plane between the serratus posterior superior muscle and intercostal muscles. All patients subsequently undergo standardized general anesthesia and receive postoperative patient-controlled analgesia with intravenous morphine.
Interventions
Intrathecal morphine is administered at a dose of 5 micrograms per kilogram diluted in 3 milliliters of saline via spinal injection at the lumbar level before induction of general anesthesia.
Ultrasound-guided serratus posterior superior intercostal plane block is performed before induction of general anesthesia using 30 milliliters of 0.25 percent bupivacaine with epinephrine injected into the interfascial plane between the serratus posterior superior muscle and intercostal muscles.
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years
- American Society of Anesthesiologists physical status I to III
- Scheduled for elective video-assisted thoracoscopic surgery including wedge resection, segmentectomy, or lobectomy
You may not qualify if:
- Refusal to participate
- Pregnancy
- Morbid obesity (body mass index greater than 40 kg per square meter)
- Allergy to opioids, local anesthetics, or nonsteroidal anti-inflammatory drugs
- Neuropsychiatric disorders, cognitive impairment, or inability to communicate
- History of substance abuse
- Use of anticoagulant therapy or presence of bleeding disorders
- Active systemic infection
- Severe cardiovascular, hepatic, renal, or endocrine disease
- Chronic pain syndrome or ongoing chronic pain treatment
- Emergency surgery or prior ipsilateral thoracic surgery
- Preoperative opioid use
- Significant intraoperative or postoperative bleeding or hemodynamic instability
- Requirement for prolonged postoperative mechanical ventilation longer than 18 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ondokuz Mayis University
Atakent, Samsun, 55270, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
April 9, 2026
First Posted
April 20, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04